- Home
- UDMY vs NEO Comparison
UDMY vs NEO Comparison
Compare UDMY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- NEO
- Stock Information
- Founded
- UDMY 2009
- NEO 2001
- Country
- UDMY United States
- NEO United States
- Employees
- UDMY N/A
- NEO N/A
- Industry
- UDMY Other Consumer Services
- NEO Precision Instruments
- Sector
- UDMY Real Estate
- NEO Health Care
- Exchange
- UDMY Nasdaq
- NEO Nasdaq
- Market Cap
- UDMY 1.1B
- NEO 965.2M
- IPO Year
- UDMY 2021
- NEO 1999
- Fundamental
- Price
- UDMY $6.94
- NEO $7.00
- Analyst Decision
- UDMY Buy
- NEO Buy
- Analyst Count
- UDMY 11
- NEO 9
- Target Price
- UDMY $10.10
- NEO $13.31
- AVG Volume (30 Days)
- UDMY 1.0M
- NEO 2.0M
- Earning Date
- UDMY 07-30-2025
- NEO 07-28-2025
- Dividend Yield
- UDMY N/A
- NEO N/A
- EPS Growth
- UDMY N/A
- NEO N/A
- EPS
- UDMY N/A
- NEO N/A
- Revenue
- UDMY $790,019,000.00
- NEO $672,361,000.00
- Revenue This Year
- UDMY $1.87
- NEO $13.97
- Revenue Next Year
- UDMY $4.15
- NEO $11.36
- P/E Ratio
- UDMY N/A
- NEO N/A
- Revenue Growth
- UDMY 5.43
- NEO 10.10
- 52 Week Low
- UDMY $5.68
- NEO $6.08
- 52 Week High
- UDMY $10.61
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- UDMY 43.44
- NEO 40.74
- Support Level
- UDMY $6.84
- NEO $6.90
- Resistance Level
- UDMY $7.10
- NEO $7.42
- Average True Range (ATR)
- UDMY 0.25
- NEO 0.39
- MACD
- UDMY -0.08
- NEO -0.00
- Stochastic Oscillator
- UDMY 11.11
- NEO 13.01
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.